TCG
CVS icon

Transcendent Capital Group’s CVS Health CVS Stock Holding History

Transcendent Capital Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-917
Closed -$41.2K – 156
2024
Q4 		$41.2K Sell
917
-936
-51% -$52.5K 0.02% 209
2024
Q3 		$117K Hold
1,853
– – 0.06% 138
2024
Q2 		$109K Hold
1,853
– – 0.06% 126
2024
Q1 		$148K Buy
1,853
+1,605
+647% +$123K 0.09% 109
2023
Q4 		$19.6K Buy
+248
New +$17.7K 0.01% 213

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Transcendent Capital Group's CVS Position: Q1 2025 in Review

Transcendent Capital Group sold out of CVS Health (CVS) in Q1 2025, closing a stake of 917 shares — an estimated $41.2K sold.

Transcendent Capital Group first reported a position in CVS in Q4 2023 and held it in 5 quarters. The position peaked at $148K in Q1 2024. 1,756 funds tracked by Wall St. Rank hold CVS as of Q1 2025.

  • Transcendent Capital Group reported no remaining CVS Health position as of Q1 2025 after selling out during the quarter.
  • Transcendent Capital Group sold 917 CVS Health shares in Q1 2025, an estimated $41.2K.
  • Transcendent Capital Group first reported a position in CVS Health in Q4 2023 and held it in 5 quarters.
  • Transcendent Capital Group's CVS Health position peaked at $148K in Q1 2024.
  • 1,756 funds tracked by Wall St. Rank held CVS Health as of Q1 2025.

Based on Transcendent Capital Group's 13F filing for Q1 2025, filed 2 May 2025.